SG Americas Securities, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$896,000
+23.1%
44,429
+127.6%
0.00%
+33.3%
Q2 2021$728,000
+35.3%
19,519
-7.3%
0.00%0.0%
Q1 2021$538,000
-23.7%
21,050
-34.2%
0.00%
-25.0%
Q4 2020$705,000
+14.6%
31,994
-6.4%
0.00%0.0%
Q3 2020$615,000
-2.8%
34,184
+37.1%
0.00%
-20.0%
Q2 2020$633,000
+115.3%
24,934
+56.0%
0.01%
+66.7%
Q1 2020$294,000
+50.0%
15,986
+79.3%
0.00%
+50.0%
Q4 2019$196,000
+19.5%
8,917
-21.8%
0.00%
+100.0%
Q3 2019$164,000
-59.6%
11,396
-55.8%
0.00%
-66.7%
Q2 2019$406,000
-28.6%
25,799
-33.6%
0.00%
-40.0%
Q1 2019$569,00038,8250.01%
Other shareholders

There were no reported owners of DICERNA PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of DICERNA PHARMACEUTICALS INC shareholders